The Sample Preparation Market will grow at a CAGR of 6.4% during the forecast period to reach $11.99 billion by 2030. Sample preparation is the crucial step of the analytical procedure. Without proper preparation steps, such as extraction, isolation, and purification, contaminants co-exist with the samples, including proteins and nucleic acids, and often inhibit enzymatic amplification in cell samples, causing poor reproducibility and sensitivity. Hence, the sample preparation step helps to form a desired analyte that can be detected with the help of several instruments.
The growth of this market is driven by technological advances in sample preparation procedures, increasing process automation in laboratories, the development of bioclusters for supporting research activities, increasing R&D investments in the pharmaceutical and biotechnology industries, and active research in genomics and proteomics. Additionally, the widening applications of sample preparation in emerging economies and the increasing focus on personalized medicines are expected to offer significant market growth opportunities.
Here are the top 10 companies operating in the Sample Preparation Market
Thermo Fisher Scientific Inc. (U.S.)
Founded in 1956 and headquartered in Massachusetts, U.S., Thermo Fisher Scientific Inc. is a biotechnology company engaged in life sciences research, improving patient diagnostics, and increasing laboratory productivity. The company operates through four reportable segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Biopharma Services. The company operates in the sample preparation market through all segments by providing liquid handling systems, purification systems, purification kits, and isolation kits. The company offers sample preparation products to pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies, as well as environmental, industrial, and food research and development companies.
The company has a direct presence through its regional offices and production sites in the U.S., Mexico, Brazil, Germany, Belgium, Austria, the U.K., Italy, the Netherlands, South Africa, the UAE, India, China, Japan, Australia, and the Republic of Korea. Some of its subsidiaries operating in the sample preparation market are Fisher Scientific International Inc. (Delaware), Fisher Clinical Services (Korea) Co., Ltd (Korea), Fisher Germany Holdings GmbH (Germany), Fisher Scientific Brazil Inc. (Delaware), Fisher Clinical Services Japan K.K. (Japan), Thermo Fisher Scientific C.V. (Netherlands), Thermo Fisher Scientific Middle East Holdings Inc. (South Africa), and Thermo CRS Holdings Ltd. (Canada).).
Bio-Rad Laboratories, Inc. (U.S.)
Founded in 1952 and headquartered in California, U.S., Bio-Rad Laboratories, Inc. is a distributor and manufacturer of clinical diagnostic products and life science research. The company manufactures and supplies a wide array of products and systems to separate complex chemical and biological materials and to identify, analyze, and purify their components. The company’s products are used by various end users engaged in life science research, healthcare, and analytical chemistry markets.
Bio-Rad Laboratories operates through two reportable segments: Clinical Diagnostics and Life Sciences. The company operates in the sample preparation market through both segments by providing pipetting systems, microplate washers, purification kits, and software. The company’s offerings cater to universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories.
The company has a direct presence through its manufacturing, research, and distribution facilities in the U.S., France, Switzerland, Germany, Belgium, Switzerland, and Singapore. The company has a direct distribution source in over 35 countries outside the U.S., including Afghanistan, France, Hong Kong, Japan, Korea, Iceland, Germany, Australia, Spain, the Netherlands, and South Africa.
Some of its subsidiaries operating in the sample preparation market are Bio-Rad Laboratories SAS (France), Bio-Rad Laboratories K.K. (Japan), Bio-Rad Laboratories, S.A. (Spain), Bio-Rad Laboratories AB (Sweden), Bio-Rad Laboratories AG (Switzerland), Bio-Rad Laboratories Limited (U.K.), Bio-Rad Laboratories G.m.b.H. (Germany), Bio-Rad Korea Limited (Korea), and Bio-Rad China Ltd. (Hong Kong.
Agilent Technologies, Inc. (U.S.)
Founded in 1999 and headquartered in California, U.S., Agilent Technologies, Inc. provides application-focused solutions for the life sciences, diagnostics, and applied chemical markets. It operates through three business segments: Life Sciences & Applied Markets, Diagnostics & Genomics, and Agilent CrossLab. The company operates in sample preparation markets through its Life Sciences & Applied Markets business segment by providing sample preparation plates, filters, extraction kits, liquid handling systems, and sample preparation workstations.
The Life Sciences & Applied Markets business primarily focuses on five markets, namely the pharmaceutical, biopharmaceutical, CRO & CMO market, the academic and government markets, the chemicals & advanced materials market, the environmental & forensics market, and the food market. The Life Sciences & Applied Markets products and applications include various technologies such as liquid chromatography, gas chromatography, mass spectrometry, spectroscopy, software and informatics, laboratory automation and robotics, vacuum technology, cell analysis, chemistries and supplies, and remarketed instruments.
The company has a direct presence through research and development and manufacturing sites in the U.S., Australia, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore, and the U.K. With its subsidiaries and strong distribution network, the company also has a presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. As of October 2021, the company had 6,900 people in the life sciences and applied markets business. In fiscal year 2022, the company had 53,800 customers in life sciences and applied markets business.
Some of its subsidiaries operating in the sample preparation market are Agilent Technologies LLC (Russia), Agilent Technologies Company Limited (China), Agilent Technologies Canada Inc. (Canada), Agilent Technologies UK Limited (U.K.), Agilent Technologies Italia S.p.A. (Italy), and Agilent Technologies Singapore Pte. Ltd. (Singapore)
QIAGEN N.V. (Netherlands)
Founded in 1984 and headquartered in Venlo, Netherlands, QIAGEN N.V. is engaged in developing and selling instruments, consumables, and digital bioinformatics solutions for oncology, infectious diseases, sexual & reproductive health, TB management, precision diagnostics, and point-of-care testing research. The company operates in two business segments: Molecular Diagnostics and Life Sciences. The company operates in the sample preparation market through both segments.
QIAGEN offers its products to more than 500,000 customers and has 35 subsidiaries operating across 25 countries through sales and manufacturing offices and operational sites, including the U.S., Canada, Germany, Spain, the U.K., France, Italy, the Netherlands, Sweden, Turkey, Sweden, Brazil, Mexico, China, Hong Kong, Taiwan, South Korea, India, and South Africa. Qiagen has manufacturing and production facilities in the U.S., Germany, China, and the U.K.
The company has a strong distribution network through its partners across 60 countries worldwide, and some of the subsidiaries operating in the sample preparation market are QIAGEN AG (Switzerland), QIAGEN Ltd. (U.K.), QIAGEN K.K. (Japan), QIAGEN Beverly, Inc. (U.S.), QIAGEN Deutschland Holding GmbH (Germany), QIAGEN S.r.l (Italy), and QIAGEN Finance Ltd. (Ireland).
Founded in 1668 and headquartered in Darmstadt, Germany. Merck KGaA is a science and technology company aimed to improve the health and well-being of people and advance their lives through science and technology. The company operates in three reportable segments: Healthcare, Life Science, and Electronics. The company operates in the sample preparation market through the Life Science business segment and offers more than 300,000 products through its brand—Merck Millipore.
The Life Science business segment of the company has 59 manufacturing sites across the globe and more than 100 distribution centers. The sector has corporate offices, manufacturing units, and distributors across Argentina, Germany, France, Romania, Colombia, Japan, Brazil, Belgium, Croatia, the U.S., and Iraq. Some of its subsidiaries operating in the sample preparation market are Merck Life Science Germany GmbH (Germany), Merck Millipore Ltd. (Ireland), Merck Life Science S.L.U. (Spain), Merck Chemicals and Life Science AB (Sweden), Sigma-Aldrich International GmbH (Switzerland), Sigma-Aldrich Biochemie GmbH (Germany), Merck Life Science S.r.l. (Italy), and Merck Life Science AS (Norway).
Meticulous Research in its latest publication on Sample Preparation Market has predicted the growth of 6.4% during the forecast year 2023-2030.
Danaher Corporation (U.S.)
Established in 1984 and headquartered in Washington, D.C., U.S., Danaher Corporation designs, manufactures, and markets medical, professional, industrial, and commercial products and services for various end users. The company operates through four reportable business segments, namely, Life Sciences, Biotechnology, Diagnostics, and Environmental & Applied Solutions. In March 2018, Danaher Corporation acquired Integrated DNA Technologies, Inc. (U.S.) to expand its presence in genomics research. The company operates in the sample preparation market through the Life Sciences, Biotechnology, and Diagnostics segment by providing sample preparation consumables and instruments.
The Biotechnology segment consists of various businesses, namely, bioprocessing, discovery, and medical. The Life Sciences segment consists of various businesses, namely, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization, mass spectrometry, microscopy, industrial filtration, genomic consumables, and Diagnostics segment includes businesses such as core lab – clinical, molecular diagnostics, acute care diagnostics, and pathology diagnostics.
The company has a direct presence in more than 60 countries through research and development, manufacturing, sales, distribution, service, and administrative facilities across North and South America, Europe, Asia, Oceania, and Africa. Some of its subsidiaries operating in the sample preparation market are Beckman Coulter, Inc. (U.S.), Beckman Coulter Australia Pty. Ltd. (Australia), Beckman Coulter Korea Ltd. (South Korea), Beckman Coulter France S.A.S. (France), Beckman Coulter GmbH (Germany), Beckman Coulter United Kingdom (U.K.), and Beckman Coulter India Pvt Ltd (India).
F. Hoffmann-La Roche Ltd (Switzerland)
Founded in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche Ltd is a healthcare company that develops, manufactures, and markets a wide range of healthcare solutions. The company operates through two reportable divisions, namely, Pharmaceuticals and Diagnostics. The company operates in the sample preparation market through the Diagnostics segment by providing isolation kits, and extraction kits.
The company has a geographic presence across the U.S., Germany, Switzerland, Japan, China, India, New Zealand, Australia, Latin America, and Africa. Furthermore, the company has 20 manufacturing sites and 33 research and development sites worldwide. Some of its subsidiaries are Roche Diagnostics (U.S.), Diagnostics GmbH (Germany), Roche Diagnostics France SAS (France), Roche Diagnostics S.p.A. (Italy), Roche Diagnostics International AG (Switzerland), and Roche Diagnostics Limited (U.K.).
Illumina, Inc. (U.S)
Incorporated in 1998 and headquartered in California, U.S., Illumina, Inc. is a biotechnology company that provides sequencing- and array-based solutions for genomic and genetic analysis. The company operates through two reportable segments, namely, Core Illumina and GRAIL. The company operates in the sample preparation market through the Core Illumina segment by providing sample preparation DNA and RNA kits and instruments.
Illumina provides its products to government laboratories, genomic research centers, academic institutions, hospitals, commercial molecular diagnostics laboratories, and pharmaceutical and consumer genomics companies. The company has a direct presence through manufacturing sites, research and development sites, offices, and laboratories in the U.S., Germany, New Zealand, China, France, Japan, the Netherlands, Korea, Israel, Singapore, and the U.K.
Illumina distributes its products globally in North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa through its distributors. Some of its subsidiaries operating in the sample preparation market are Illumina Australia Pty. Ltd. (Australia), Illumina Netherlands B.V. (Netherlands), Illumina GmbH (Germany), Illumina UK, Ltd. (U.K.), Illumina Italy S.r.l. (Italy), Illumina K.K. Japan (Japan), and Illumina Austria GmbH (Austria).
Founded in 1937 and headquartered in Massachusetts, U.S., PerkinElmer, Inc. is a multinational company that offers products, solutions, and services for the life sciences, diagnostics, and applied markets. It operates through two reportable business segments: Discovery & Analytical Solutions and Diagnostics. The company operates in the sample preparation market through the Discovery & Analytical Solutions segment by providing liquid handling systems, sample preparation instruments, and consumables. Discovery & Analytical Solutions serves the life sciences and applied markets.
The company has a direct presence through manufacturing and R&D facilities located in several countries, including the U.S., China, Japan, and Germany. Furthermore, the company has a strong network of sales and marketing channels and service personnel in over 38 countries and sells its products and services in over 190 countries.
PerkinElmer sells products and services predominantly through its distributors. Some of its subsidiaries operating in the sample preparation market are PerkinElmer Genetics, Inc. (U.S.), PerkinElmer do Brasil Ltda. (Brazil), PerkinElmer Instruments (Shanghai) Co. Ltd. (China), PerkinElmer Pty. Ltd. (Australia), PerkinElmer SAS (France), PerkinElmer Srl (Italy), PerkinElmer (India) Pvt Ltd. (India), PerkinElmer Technologies GmbH & Co. KG (Germany), and PerkinElmer Sverige AB (Sweden).
Hamilton Company. (U.S.)
Founded in 1950 and headquartered in Texas, U.S., Hamilton Company develops, manufactures, and customizes sample management systems, automated liquid handling workstations, and precision measurement devices. In the sample preparation market company offers automated liquid handler workstations, dispensers, and pipettes. The company is ISO 9001 certified.
Hamilton has a direct presence through sales, distributors, and offices in the Americas, Australia & Pacific Rim, Europe, the Middle East, Africa, and Asia, and has a presence through its subsidiaries in Brazil, Japan, the U.S., China, France, Germany, Spain, Italy, Sweden, England, and Switzerland.
Founded in 1998 and headquartered in Ontario, Canada, Norgen Biotek Corp. is a biotechnology company that focuses on developing products for sample preparation, sample collection, sample detection, and broad research services to the scientific group. The company operates in the sample preparation market by providing purification and isolation kits. The company is ISO 9001, ISO 13485, and ISO 15189 certified and has more than 35 issued and pending patents.
Norgen has a presence in over 50 countries and sells products predominantly through its distributors in the U.S., Canada, Mexico, Japan, Australia, New Zealand, South Korea, Brazil, France, Ireland, Russia, the Netherlands, Thailand, and Indonesia.
Tecan Group Ltd. (Switzerland)
Founded in 1980 and headquartered in Männedorf, Switzerland, Tecan Group Ltd. offers automated laboratory tools and solutions for clinical diagnostics, basic and translational research, and drug discovery. It operates through two reportable business segments, namely, the Life Sciences Business and the Partnering Business. The company operates in the sample preparation market through the Life Sciences Business segment by providing sample preparation workstations and plates.
The company has a direct presence in 70 countries through its offices, R&D sites, manufacturing sites, and sales and service network in Germany, Belgium, Austria, Australia, China, France, Italy, Japan, the Netherlands, Singapore, Spain, Sweden, the U.K., the U.S., and Vietnam. Some of its subsidiaries operating in the sample preparation market are Tecan France S.A.S. (France), Tecan Italia S.r.l. (Italy), Tecan Japan Co., Ltd (Japan), Tecan Australia Pty Ltd (Australia), Tecan UK Ltd. (U.K.), and Tecan Austria GmbH (Austria.
Founded in 1978 and headquartered in Wisconsin, U.S., Promega Corporation offers technical support and innovative solutions to the life science industry. The company offers products for various applications, including drug discovery, clinical research & diagnostics, infectious diseases, and human identification & forensics. The company operates in the sample preparation market by providing automated sample preparation liquid handler and liquid handler accessories.
The company has direct presence through offices in Australia, the Netherlands, Brazil, China, Denmark, Estonia, Finland, France, Germany, India, Ireland, Italy, Japan, Republic of Korea, Luxembourg, Norway, Poland, Singapore, Spain, Sweden, Switzerland, the U.K., the U.S., distributors in North America, Europe, Pacific Asia, Latin America, and Africa & Middle East, and manufacturing, dispensing, and packaging facilities in the U.S, China, and South Korea.
Authoritative Research on the Sample Preparation Market- Global Opportunity Analysis and Industry Forecast (2023-2030)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
